NorDiag held an extraordinary general meeting on 16 March 2007. 72.4 % of the share capital was represented in the general meeting. The minutes from the general meting are available at www.newsweb.no and on the Company’s website www.nordiag.no.

The general meeting made the resolutions required to complete the acquisition of all the shares in Genpoint (see separate disclosure), including the issuance of consideration shares, the issuance of shares in the private placement and authorization to the Board to issue new shares.

The general meeting elected Hans Hekland as chairman of the board of directors and J. Frode Vaksvik, Mathias Uhlèn and Jan Olav Steensland as new board members. The new board of directors consists of the following: Hans Hekland (chairman), Gisela Sitbon, Annika Lindblom, Robert Allnutt, Elke Holinski-Feder, J. Frode Vaksvik, Mathias Uhlen and Jan Olav Steensland.

Following the acquisition of Genpoint, NorDiag has appointed Mårten Wigstøl as CEO of the Company, and Christian Horn has been appointed SVP M&A and Strategic affairs.